HHS Says It Appropriately Certified Clinics for Drug Discounts

A federal health agency is opposing a court challenge from drugmakers over whether it lawfully allowed certain clinics to obtain discounted medicines through a government pricing program.

The US Health Resources and Services Administration is arguing the agency established appropriate procedures to certify clinics under Sagebrush Health Services for participation in the 340B Drug Pricing Program.

Eli Lilly & Co., Amgen Inc., and UCB Inc.‘s “claims are misplaced,” the government said in a motion for summary judgment filed April 24 to the US District Court for the District of Columbia.

“HRSA’s compliance check removed more than forty ...